AUD2.49
0.00% today
Australia, Jul 29, 08:10 am CET
ISIN
AU000000MSB8
Symbol
MSB

Mesoblast Target price 2025 - Analyst rating & recommendation

Mesoblast Classifications & Recommendation:

Buy
78%
Hold
22%

Mesoblast Price Target

Target Price AUD2.96
Price AUD2.49
Potential
Number of Estimates 3
3 Analysts have issued a price target Mesoblast 2026 . The average Mesoblast target price is AUD2.96. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 7 Analysts recommend Mesoblast to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Mesoblast stock has an average upside potential 2026 of . Most analysts recommend the Mesoblast stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '24 2025
Estimates
Revenue Million AUD 9.05 24.99
21.30% 178.01%
EBITDA Margin -1,108.18% -371.69%
35.72% 66.46%
Net Margin -1,489.72% -2,829.60%
36.49% 89.92%

5 Analysts have issued a sales forecast Mesoblast 2025 . The average Mesoblast sales estimate is

AUD25.0m
Unlock
. This is
189.61% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD30.7m 253.27%
Unlock
, the lowest is
AUD19.4m 123.25%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD9.1m 21.30%
2025
AUD25.0m 178.01%
Unlock
2026
AUD101m 305.06%
Unlock
2027
AUD370m 265.87%
Unlock
2028
AUD1.0b 176.39%
Unlock
2029
AUD925m 9.68%
Unlock
2030
AUD1.3b 42.90%
Unlock
2031
AUD1.9b 46.93%
Unlock
2032
AUD1.4b 26.41%
Unlock

5 Mesoblast Analysts have issued a net profit forecast 2025. The average Mesoblast net profit estimate is

AUD-707m
Unlock
. This is
349.36% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD-122m 23.23%
Unlock
, the lowest is
AUD-1.3b 692.53%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD-135m 7.41%
2025
AUD-707m 428.01%
Unlock
2026
AUD-393m 44.42%
Unlock
2027
AUD13.0m 103.31%
Unlock
2028
AUD-1.8m 113.63%
Unlock

Net Margin

2024 -1,489.72% 36.49%
2025
-2,829.60% 89.92%
Unlock
2026
-388.23% 86.28%
Unlock
2027
3.51% 100.90%
Unlock
2028
-0.17% 104.84%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '24 2025
Estimates
Earnings Per Share AUD -0.14 -0.61
12.50% 335.71%
P/E negative
EV/Sales 137.45

5 Analysts have issued a Mesoblast forecast for earnings per share. The average Mesoblast EPS is

AUD-0.61
Unlock
. This is
335.71% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
AUD-0.11 21.43%
Unlock
, the lowest is
AUD-1.09 678.57%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD-0.14 12.50%
2025
AUD-0.61 335.71%
Unlock
2026
AUD-0.34 44.26%
Unlock
2027
AUD0.01 102.94%
Unlock
2028
AUD0.00 100.00%
Unlock

P/E ratio

Current -17.79 121.33%
2025
-4.11 77.17%
Unlock
2026
-7.39 79.81%
Unlock
2027
223.53 3,124.76%
Unlock
2028
-1,638.50 833.01%
Unlock

Based on analysts' sales estimates for 2025, the Mesoblast stock is valued at an EV/Sales of

137.45
Unlock
and an P/S ratio of
132.06
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 386.58 157.82%
2025
137.45 65.47%
Unlock
2026
33.93 75.31%
Unlock
2027
9.27 72.67%
Unlock
2028
3.36 63.82%
Unlock
2029
3.72 10.71%
Unlock
2030
2.60 30.02%
Unlock
2031
1.77 31.94%
Unlock
2032
2.40 35.89%
Unlock

P/S ratio

Current 370.98 164.26%
2025
132.06 65.47%
Unlock
2026
32.60 75.31%
Unlock
2027
8.91 72.67%
Unlock
2028
3.22 63.82%
Unlock
2029
3.57 10.71%
Unlock
2030
2.50 30.02%
Unlock
2031
1.70 31.94%
Unlock
2032
2.31 35.89%
Unlock

Current Mesoblast Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BELL POTTER SECURITIES
Locked
Locked
Locked Jul 17 2025
CANTOR FITZGERALD
Locked
Locked
Locked Jul 17 2025
JEFFERIES
Locked
Locked
Locked Jul 17 2025
PIPER SANDLER COMPANIES
Locked
Locked
Locked Jul 08 2025
MAXIM GROUP
Locked
Locked
Locked Jul 02 2025
PIPER SANDLER COMPANIES
Locked
Locked
Locked Apr 06 2025
JEFFERIES
Locked
Locked
Locked Mar 05 2025
Analyst Rating Date
Locked
BELL POTTER SECURITIES:
Locked
Locked
Jul 17 2025
Locked
CANTOR FITZGERALD:
Locked
Locked
Jul 17 2025
Locked
JEFFERIES:
Locked
Locked
Jul 17 2025
Locked
PIPER SANDLER COMPANIES:
Locked
Locked
Jul 08 2025
Locked
MAXIM GROUP:
Locked
Locked
Jul 02 2025
Locked
PIPER SANDLER COMPANIES:
Locked
Locked
Apr 06 2025
Locked
JEFFERIES:
Locked
Locked
Mar 05 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today